Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Daratumumab for Late Antibody-Mediated Rejection — Stella

Home/Kidney Tansplant/Daratumumab for Late Antibody-Mediated Rejection

View on ClinicalTrials.gov

Recruiting

Back to Kidney Tansplant trials

Daratumumab for Late Antibody-Mediated Rejection

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Slovakia

University hospital Martin, Martin

Key details

Sponsor

University Hospital, Martin

Enrollment target

~20 participants

Started

July 2025

Primary completion

July 2026

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.